SOUL Results presented at #ACC25

First day at #ACC25, here are the results of 10 trials presented today. I counted 3 NEJM, 1 Lancet, and 1 JAMA. WARRIOR: Intensive medical therapy did not reduce major CV events at five years in women with suspected INOCA. STRIDE: Semaglutide improved walking distance, symptoms,

Educate your patients about CRP, inflammation and how it affects the heart with #CardioSmart’s latest infographic: bit.ly/4hQ3ujt #ACC25

Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study presented during a Late-Breaking Clinical Trial session at #ACC25. Check out the key findings ➡️ bit.ly/3DYGHEl

DYK that 1 in 5 adults have an Lp(a) level that is too high. Use #CardioSmart’s Lp(a) Infographic to help patients understand this condition and how it might affect their heart. bit.ly/3RxBF4F #Cholesterol #ACC25

Loved representing UAB Medicine Huntsville American College of Cardiology . Thank you Tanja Dudenbostel, MD, FASH, FAHA for the support. #ACC25 #Cardiology

Extremely grateful for the opportunity to present and experience #ACC25 representing UAB Huntsville with the best! Thank you for your encouragement and support Tanja Dudenbostel, MD, FASH, FAHA Christian Motley Soumyadeep Bag, MD🇮🇳-🇨🇦-🇺🇲 Prutha Pathak, MBBS, MPH

For Lp(a), key therapeutic question remains: will lowering of Lp(a) reduce risk for cardiovascular events? Four subquestions: 1. how much Lp(a) lowering do you need [magnitude of Lp(a) lowering] 2. for how long [duration of treatment required] 3. in which patients [threshold of

It was a privilege to present 3 posters at #ACC25. Thank you Chicago for having me and American College of Cardiology for the opportunity. Shout-out to my co- researches Aesha Patel, DO Christian Motley Alina Sehar, MD. And thank you to my mentors Tanja Dudenbostel, MD, FASH, FAHA and Dr. Urvish Patel for your continued guidance.

Time to rethink how we monitor and manage silent atrial fibrillation. New meta-analysis sheds light on symptomatic vs. asymptomatic atrial fibrillation. Raed more in#EHJ. doi.org/10.1093/eurhea… #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

ACC’s #CardioSmart recently launched a 🆕 app, CardioSmart360, designed to support treatment discussions between patients and their health care team. Find out more and download the new CardioSmart360 app for free! ➡️ bit.ly/43Vol1p #CardioX

So grateful and honored to be co-chief resident with Aesha Patel, DO! Learning so much at the Alliance for Academic Internal Medicine Conference! #chiefresidents #MedicalInnovation UAB Medicine #womeninSTEM #internalmedicine

Join us on April 10th at 7pm EST for second session of ACC MSMC April Journal Club meeting! We'll learn about ASCVD Risk Score, PCE, Framingham Study, discussing findings from MASALA. To Read: pubmed.ncbi.nlm.nih.gov/25277669/ #ACCMedStudent #JournalClub #MedEd American College of Cardiology Link below👇

CVD is the most common cause of death for people with kidney failure. CKM syndrome is defined as a health disorder caused by the connections among obesity, diabetes, chronic kidney disease & CVD. 📷 Algorithm for managing patients with CKM syndrome Stage 4

#CardioNuggets The Reynolds Risk Score refines 10-year CV risk—especially in women: ✅ Uses: Age, SBP, TC, HDL, hs-CRP, smoking, family hx 🔍 More accurate than Framingham for women Ideal for primary prevention decisions. #CardioTwitter #Prevention #Lipids

Palliative care in advanced CVD is essential to enhance quality of life, extending beyond end-of-life care to encompass the entire disease course. ✍🏼 Lucinda J. Graven PhD, APRN, FAHA, FAAN Lisa Kitko Martha Abshire Saylor Larry A. Allen, MD Angela Durante Lorraine Evangelista Amy G. Fiedler, MD Rachel Wells, PhD, RN

C-reactive protein (CRP) is a marker of inflammation and can help predict #heartdisease risk 📄 Help your patients understand CRP, inflammation and how it affects the heart with #CardioSmart’s latest infographic. Learn more: bit.ly/3Euhems

New ASPC Clinical Practice Statement🫀: Framework to improve cardiometabolic care for South Asians—individual to population level. ow.ly/glCT50VGq9Y Pradeep Natarajan Jaideep Anand Rohatgi Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Johns Hopkins Ciccarone Center #SouthAsianHealth #HeartHealth #ASPC

🆕 #ACCEd Tackles hs-CRP’s Role in #CVD Check out the infographic 👇 which details the role of hs-CRP and influencing factors, along with materials on hs-CRP codes, recommendations, approaches, and further research. Explore the course: bit.ly/4iXhusn

JACC STATE-OF-THE-ART REVIEW: do you have problems understanding all the new drugs to lower triglycerides and remnant cholesterol: lipid and side effects, target populations, approved or not by FDA+EMA? Ask Tybjærg Nordestgaard et al explain the details authors.elsevier.com/a/1l4pB2d9GI27…